Phase IIa trial of travoprost (OTX-TP) in patients with glaucoma or ocular hypertension
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2015
At a glance
- Drugs Travoprost (Primary) ; Timolol
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Ocular Therapeutix
- 06 Oct 2015 Primary endpoint has been met. (Change in Intraocular pressure from baseline at day 25), as per Envisia Therapeutics media release.
- 06 Oct 2015 Results published in as per Envisia Therapeutics media release.
- 29 Oct 2014 New trial record